Yale Researchers Awarded $40 Million to Lead New VA Study to Evaluate Esketamine for Treatment Resistant Depression
April 28, 2023
April 28, 2023
NEW HAVEN, Connecticut, April 28 (TNSfund) -- Yale School of Medicine issued the following news:
Somaia Mohamed, MD, PhD, associate professor of psychiatry, is lead co-investigator of a Department of Veterans Affairs (VA) study that has been awarded $40 million to evaluate the effectiveness of a novel antidepressant medicine, esketamine, for veterans and others with treatment resistant depression (TRD).
The VA Aripiprazole vs. Esketamine for Treatment Resistant Depressi . . .
Somaia Mohamed, MD, PhD, associate professor of psychiatry, is lead co-investigator of a Department of Veterans Affairs (VA) study that has been awarded $40 million to evaluate the effectiveness of a novel antidepressant medicine, esketamine, for veterans and others with treatment resistant depression (TRD).
The VA Aripiprazole vs. Esketamine for Treatment Resistant Depressi . . .